SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-197594
Filing Date
2017-06-08
Accepted
2017-06-08 06:17:06
Documents
5
Period of Report
2017-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d362964d8k.htm 8-K 41812
2 EX-2.1 d362964dex21.htm EX-2.1 424310
3 EX-10.1 d362964dex101.htm EX-10.1 33046
4 EX-99.1 d362964dex991.htm EX-99.1 21882
5 GRAPHIC g362964010.jpg GRAPHIC 3372
  Complete submission text file 0001193125-17-197594.txt   527007
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 17898575
SIC: 2834 Pharmaceutical Preparations